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Low-Dose Computed Tomography With
Two- and Three-Dimensional Postprocessing
as an Alternative to Plain Radiography for
Intrathecal Catheter Visualization:
A Phantom Pilot Study
Elmar M. Delhaas, MD*†; Aad van der Lugt, MD, PhD†
Objectives: In intrathecal drug delivery, visualization of the device has been performed with plain radiography. However, the visibil-
ity of the related structures can be problematic. In troubleshooting, after the contrast material injection via the catheter access port, a
computed tomography (CT) scan has been used. In troubleshooting, we also used a non-contrast CT scanwith 2D and 3D reconstruc-
tions. With the current phantom study, we aimed to obtain high-resolution imaging of a poor opaque catheter with the use of a low-
dose single-energy 2D and 3D CT scanwith limited radiation exposure as a substitute for plain radiography.
Materials and Methods: The catheter was placed into a fatty substance andmounted on an anthropomorphic abdomen phantom
followed by CTwith varying kVp settings andwith added tin beam ﬁltering. Dose levels corrected based on the spinal catheter tip on
T8would result in a calculated effective dose in the range of themSv’s calculated for the plain x-ray examination.
Results: Ultimately, Sn100 kVp has the best trade-off between visibility, artifacts, and noise for a ﬁxed dose. Although 3D VRT
imaging was challenging at this low dose level, we could make a full evaluation possible with complementary 2D projections.
Conclusions: We could correctly identify the catheter and related structures, which supports the investigation of this in vivo
and side-by-side evaluation with plain radiography. If found superior, then this technique may be able to replace plain radiog-
raphy, while providing better visualization and acceptable radiation exposure.
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INTRODUCTION
Intrathecal drug administration using the implantable SynchroMed
II delivery device (Medtronic Inc., MN, USA) is well-established in
treating intractable pain, spasticity, and dystonia. Despite generally
favorable and safe outcomes and continuous advancements in
manufacturing technology, adverse events related to the pump and
catheter still occur.
Visualization of the pump and catheter is performed after
device implantation and in troubleshooting to conﬁrm the correct
pump and catheter positioning. Historically, the cornerstone for
the diagnosis of a catheter-related problem was plain radiogra-
phy, which was in most cases, but not in all, acceptable in the
older catheter types (1). However, the opacity of the latest devel-
oped clinically used Ascenda catheter is more problematic
(Figs. 1a, 5c) (1).
In troubleshooting, we, therefore, extended the plain radiogra-
phy with catheter access port (CAP) CT myelography with high-
resolution two- (2D) (Fig. 1b) and three-dimensional (3D) (Fig. 1c,
d) (2–8), reconstructions based on maximum intensity projection
(MIP) (9), multiplanar reformation (MPR) (9), and volume rendering
techniques (VRTs) (9). With this approach, we could provide opti-
mal visualization of the entire catheter pathway (Fig. 1b–d) (7)
and reduce beam-hardening artifacts around the implanted tita-
nium pump. Normally, compared to plain radiography, CT has the
disadvantage of an increased radiation dose. With the current
phantom study, we aimed to obtain high-resolution imaging of
the Ascenda catheter with the use of a low-dose single-energy 2D
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and 3D CT scan with limited radiation exposure as a substitute for
plain radiography. Based on this experience we now intend to
replace plain radiography by CT in all cases where imaging of the
pump and catheter is needed.
MATERIALS AND METHODS
We tested the visualization of the Ascenda catheter placed into a
fatty substance and mounted on an Anthropomorphic Abdomen
Phantom (QRM GmbH, Moehrendorf, Germany) with a 2.5 cm fat
equivalent extension ring (Fig. 2). We performed a low-dose single-
energy spiral CT scan (SECT) using amulti-slice CT scanner (SOMATOM
Drive VA62A, Siemens Healthcare GmbH, Erlangen, Germany). Scans
were performed with varying kVp settings (80, 100, and 140) and with
added tin (Sn) beam ﬁltering (Sn100, Sn140) to evaluate a trade-off
between the catheter visibility, the pump beam-hardening artifacts,
and the x-ray energy level. Because a Sn ﬁlter at 80 and 120 kVp is not
available, this setting was not used. By adapting the tube load (inmAs),
three scans per kVp setting were performed with three ﬁxed values of
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Figure 1. Visibility of spinal catheter with CT in troubleshooting. Plain radiography: invisible Ascenda catheter and visible type 8731SC catheter segment
(a, red arrow), and dorsal to the spine several hardly recognized structures of both catheters on (a, green arrow). Zoomed two-dimensional maximum intensity
projection (b) and three-dimensional volume rendered images (c, d) revealed visible Ascenda structures: catheter (blue arrow), catheter-catheter connector (yellow
arrow), ﬁxation anchor (orange arrow), as well as retained 8731SC catheter parts (red arrow).
Figure 2. CT imaging of a catheter mounted on a phantom with extension ring. Ascenda intrathecal catheter in a fatty substance, visible catheter (blue arrow)
with ﬁxation anchor (orange arrow) and catheter-catheter connector on CT 2D MIP images (yellow arrow). A dose of 80 kVp showed most artifacts (beam harden-
ing [green arrow] and noise of phantom body [red arrow]), 100 kVp artifacts less but still present, 140 kVp reduced beam hardening, noise still present, Sn100 kVp
strongly reduced artifacts, and Sn140 kVp minimum artifacts but more noise visible and less catheter visibility.
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the dose length product (DLP) for a 20 cm scan range on the phantom:
15, 30, and 60 mGy × cm. These dose levels, corrected for an average
50 cm scan range based on the spinal catheter tip on T8, would result
in a calculated effective dose of, respectively, 0.6, 1.1, and 2.3 mSv.
These values are approximately less than, virtually equal to, and more
than the dose level of 0.7 mSv previously used in plain x-ray examina-
tion of the old catheters in a standard patient.
RESULTS
The protocol with a DLP of 30 mGy × cm has an optimum radiation
dose level for all kVp settings because the lowest dose resulted in poor
visualization and the highest dose resulted in better visualization than
needed. A low energy level of 80 kVp had the highest contrast
between the catheter and the surrounding tissue, beneﬁting catheter
visualization, but also had the highest level of beam-hardening arti-
facts around the pump. The highest energy level of 140 kVp with
added Sn ﬁltering hadminimal artifacts, but the reduced contrast cau-
sed the catheter visibility to become insufﬁcient. Sn ﬁltering resulted
in increased dose efﬁciency with an improved signal-to-noise ratio for
the same dose in this phantom study (Fig. 2, 100 kVp vs. Sn100 kVp).
Ultimately, Sn100 kVp has the best trade-off between visibility, arti-
facts, and noise for a ﬁxed dose (Fig. 2). The clinical CT settings are
summarized in Fig. 3. Although 3D VRT imaging was challenging at
this lowdose level, we couldmake a full evaluation possible with com-
plementary 2DMIP andMPR projections (Figs. 4 and 5). However, with
Sn ﬁlter, not all metal-related artifacts that obscure adjacent tissues
could be suppressed. Additional improvement in visualization of the
pump, proximal catheter and surrounding soft-tissue structures (10)
could be achieved with the use ofmetal artifact reduction (MAR) algo-
rithm (iMAR [Siemens], Smart-MAR [GE Healthcare], O-MAR [Philips],
SEMAR [Canon]) (11) which suppresses the scattering in the images
caused by themetal pump (Fig. 5).
DISCUSSION
A low-dose CT scan for visualization of the pump and catheter with
an equivalent radiation dose to conventional plain radiography is fea-
sible. To extend CT with 2D and 3D reconstructions will be of value
for the postoperative evaluation of a normal drug delivery system
and for the proper diagnosis in troubleshooting. The optimal DLP
was 30 mGy× cmwith radiation exposure of 1.1mSv for a scan range
of 50 cm, which is close to the dose of plain radiography images. The
dose of plain radiography in our center was approximately 0.7 mSv,
although a value of 3.6 mSv for at least six needed plain radiography
images has been reported (12). We prefer the use of 100 kVp
with the Sn ﬁlter. The beneﬁt of the ﬁlter use is the reduction of
beam-hardening artifacts originating from the metal pump, but not
all metal-related artifacts that obscure adjacent tissues can be
suppressed. Application of a MAR algorithm can thereby be of help.
When Sn ﬁlter is used, the obtained narrowed and increased mean
energy level of the x-ray tube spectrum will create an improvement
in the overall image quality (13). The choice for an increase in kVp
resulted in a decrease in the contrast between the catheter and the
surrounding tissue, which is accompanied by a reduction in artifacts.
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Figure 3. Single energy protocol low-dose CT.
Figure 4. Low-dose SECT 2D/3D imaging. Sn100 kVp scan with an effective dose 0.8 mSv. A combination of MPR, MIP, and VRT is used to follow the Ascenda
catheter (blue arrow), pump-catheter connection (red arrow), catheter-catheter connection (yellow arrow), ﬁxation anchor (orange arrow) and pump. Postoperative
air visible with MPR (b, white arrow), invisible with MIP (a) and is a potential cause of artifacts in MIP and VRT which may mimic a pump-catheter disconnection.
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Furthermore, the choice for Sn ﬁltering resulted in an additional
decrease in the contrast between the catheter and the surrounding
tissue, which is accompanied by an increased signal-to-noise ratio.
Another disadvantage is the need for higher mAs settings, which
may limit the increase of scan speed if the patient is moving, and
which is not uncommon in our spastic patient group. In the relatively
small phantom, we could omit the beam hardening with Sn100 kVp
(Fig. 2). In obese patients or with the hindrance of upper extremity
contractures, higher radiation dose values may be needed. This
objective could be automatically realized with the automatic mA
exposure modulation setup of a CT scanner. For a deﬁnite conclusion
and the application of CT in vivo using CT scanners from different
vendors, imaging protocols per scanner should be developed.
CONCLUSION
The positive ﬁndings of our phantom study in correctly identify-
ing the catheter components supports the in vivo evaluation and
a side-by-side comparison with plain radiography. If found
superior, then this technique may be able to replace plain radiog-
raphy, while providing better visualization and acceptable radia-
tion exposure.
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COMMENTS
Whilst it is easy to diagnose there is a problem with an intrathecal
pump/catheter unit (increased pain, increased spasticity) it can some-
times be far from easy to separate underdosing from treatment
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Figure 5. Surplus catheter behind the pump. 3D VRT reconstruction (a) with
iterative metal artifact reduction reconstruction algorithm (b) showing a nor-
mal course of surplus catheter length behind the pump, which is invisible on
plain radiography (c, white arrow) and CT (b). The Ascenda catheter cannot
be followed along its track on plain radiography (c); the only structures visible
are the catheter-catheter connector (green arrow) and the ﬁxation anchor
(orange arrow).
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refractoriness or pump malfunction from catheter fracture. This can
require a review of the pump residual returns over time, a ﬂuoros-
copy rotor study, a side port ﬂuid access withdrawal test, side port
catheter dye study etcetera. Troubleshooting algorithms and logic
are critical for establishing the correct diagnosis.
A catheter dye study is often needed. This can be complex espe-
cially when no aspiration of ﬂuid from the side port is forthcoming
as in that scenario a bolus of drug (baclofen or morphine) will be
delivered to the patient before the radiological dye enters the CSF
and this may have clinical consequences for the patient and man-
date in hospital observation.
An imaging assessment system that could replace this process
would be a welcome advance in clinical care. It would allow plan-
ning of deﬁnitive surgical replacement or repair based on imaging
results without having accessed the side port.
From here clinical studies should follow. The proof is in the pud-
ding that new imaging modalities should provide more information
more reliably and reduce complications. These CT techniques may




Short article but very clear in deﬁning the problem of not being
to visualize catheter continuity without additional expense and has-
sle of doing a pump side port myelogram.
Timothy Lubenow, MD
Chicago, IL, USA
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